Gaining Ground: Olema Pharmaceuticals Inc (OLMA) Closes Lower at 10.82, Down -3.48

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Olema Pharmaceuticals Inc (NASDAQ: OLMA) closed at $10.82 in the last session, down -3.48% from day before closing price of $11.21. In other words, the price has decreased by -$3.48 from its previous closing price. On the day, 2.74 million shares were traded. OLMA stock price reached its highest trading level at $11.4 during the session, while it also had its lowest trading level at $10.55.

Ratios:

We take a closer look at OLMA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.61 and its Current Ratio is at 9.61. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on April 02, 2024, initiated with a Buy rating and assigned the stock a target price of $24.

On January 30, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $20.

On July 21, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $21.Oppenheimer initiated its Outperform rating on July 21, 2023, with a $21 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 04 ’24 when Graham G. Walmsley sold 1,175,000 shares for $14.85 per share. The transaction valued at 17,448,750 led to the insider holds 700,761 shares of the business.

Harmon Cyrus sold 5,000 shares of OLMA for $61,650 on Jun 04 ’24. The Director now owns 781,283 shares after completing the transaction at $12.33 per share. On Jun 03 ’24, another insider, Harmon Cyrus, who serves as the Director of the company, sold 5,000 shares for $10.93 each. As a result, the insider received 54,650 and left with 786,283 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OLMA now has a Market Capitalization of 605203712 and an Enterprise Value of 357999392.

Stock Price History:

Over the past 52 weeks, OLMA has reached a high of $17.79, while it has fallen to a 52-week low of $7.78. The 50-Day Moving Average of the stock is 0.09%, while the 200-Day Moving Average is calculated to be -12.77%.

Shares Statistics:

According to the various share statistics, OLMA traded on average about 937.90K shares per day over the past 3-months and 1009550 shares per day over the past 10 days. A total of 54.99M shares are outstanding, with a floating share count of 48.62M. Insiders hold about 13.08% of the company’s shares, while institutions hold 95.89% stake in the company. Shares short for OLMA as of 1718323200 were 7784831 with a Short Ratio of 8.30, compared to 1715731200 on 8539476. Therefore, it implies a Short% of Shares Outstanding of 7784831 and a Short% of Float of 24.6.

Most Popular